Filing Details

Accession Number:
0001140361-10-017024
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-04-20 13:00:00
Reporting Period:
2010-04-16
Filing Date:
2010-04-20
Accepted Time:
2010-04-20 18:06:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1124105 Targacept Inc TRGT Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1295829 S William Caldwell C/O Targacept, Inc.
200 East First Street, Suite 300
Winston-Salem NC 27101
Svp - Drug Discovery And Dev. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-04-16 36,946 $5.10 44,681 No 4 M Direct
Common Stock Disposition 2010-04-16 36,946 $23.02 7,735 No 4 S Direct
Common Stock Acquisiton 2010-04-19 100 $5.10 7,835 No 4 M Direct
Common Stock Disposition 2010-04-19 100 $23.00 7,735 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2010-04-16 3,968 $0.00 3,968 $5.10
Common Stock Stock Option (Right to Buy) Disposition 2010-04-16 6,484 $0.00 6,484 $5.10
Common Stock Stock Option (Right to Buy) Disposition 2010-04-16 10,750 $0.00 10,750 $5.10
Common Stock Stock Option (Right to Buy) Disposition 2010-04-16 15,744 $0.00 15,744 $5.10
Common Stock Stock Option (Right to Buy) Disposition 2010-04-19 100 $0.00 100 $5.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2002-02-15 2012-02-14 No 4 M Direct
0 2003-01-14 2013-01-13 No 4 M Direct
0 2013-01-30 No 4 M Direct
7,345 2013-10-30 No 4 M Direct
7,245 2013-10-30 No 4 M Direct
Footnotes
  1. This option vested in installments and became vested in full upon completion of the issuer's initial public offering.
  2. This option vested in installments and became vested in full on September 30, 2007.